Finsbury Worldwide Pharm Tst PLC
20 December 2004
FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC
20 December 2004
Warrant Dealing Facility
Further to the announcement by Finsbury Worldwide Pharmaceutical Trust PLC (the
'Company') on 19 November 2004 relating to, inter alia, the issue to qualifying
shareholders in the Company of warrants to subscribe for ordinary shares in the
Company ('Warrants') and the arrangement of a dealing facility through Close
Brothers Securities to provide those qualifying shareholders unable to, or
deciding against, retaining their Warrants with the ability to sell them (the '
Warrant Dealing Facility'), the Board announces that 1,886,389 Warrants have
been allotted to qualifying shareholders electing to sell their Warrants and
that Close Brothers Securities has agreed to buy all such Warrants at a price of
80p per Warrant. Following this issue, the Company will have 10,907,180 Warrants
in issue.
It is expected that in respect of sale proceeds from the Warrant Dealing
Facility payments will be made in CREST and cheques will be despatched to
non-CREST holders no later than 24 December 2004. However, shareholders will
not be entitled to any proceeds from the disposal of their Warrants if the
proceeds in respect of their holding are under £3.00, with such proceeds being
retained for the benefit of the Company.
Enquiries
Alastair Smith
Close Finsbury Asset Management Limited Tel: 020 7426 6240
Nathan Brown
Close Brothers Securities Tel: 020 7621 5572
Notes
Close Brothers Securities, a division of Winterflood Securities Limited which is
authorised and regulated in the United Kingdom by the Financial Services
Authority, is acting for Finsbury Worldwide Pharmaceutical Trust PLC (the '
Company') in relation to the Proposals (as defined in the prospectus issued by
the Company dated 19 November 2004) and for no other person and will not be
responsible to any other person other than the Company for providing the
protections offered to customers of Close Brothers Securities or for providing
advice in relation to the Proposals. Shareholders should note than Close
Brothers Securities is not acting for them in respect of the Warrant Dealing
Facility and will not regard them as its customer or be responsible to them for
providing the protections offered to customers of Close Brothers Securities or
for providing advice in relation to the Warrant Dealing Facility.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.